PAR 0.00% 22.5¢ paradigm biopharmaceuticals limited..

Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study, page-376

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 801 Posts.
    lightbulb Created with Sketch. 167
    I'm hoping that it is purely by chance, however, the participant dropout rate for the PARA _OA_008 is a little concerning, especially as we are not privy to the reasons for it occurring.
    * 2 placebo doses per week - 22 enrolled and 0 dropped out
    * 1 iPPS and 1 placebo per week - 20 enrolled and 3 dropped out
    * 2 iPPS doses per week - 19 enrolled and 4 dropped out.

    I'd love to know why the dropout rate was highest for the recipients that received the greatest amount of iPPS in the trial and lowest for the placebo recipients. It was a double-blind study however due to being a fairly small recipient number (n) one should not draw too many negative conclusions, but something irks me about it.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.000(0.00%)
Mkt cap ! $78.73M
Open High Low Value Volume
23.0¢ 23.0¢ 21.5¢ $78.13K 350.8K

Buyers (Bids)

No. Vol. Price($)
2 64880 22.0¢
 

Sellers (Offers)

Price($) Vol. No.
22.5¢ 43479 1
View Market Depth
Last trade - 16.10pm 11/11/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.